Research programme: orexin 1 inhibitors - EvotecAlternative Names: Orexin 1 antagonist - Evotec
Latest Information Update: 17 Oct 2016
At a glance
- Originator Evotec AG
- Developer C4X Discovery; Evotec AG
- Mechanism of Action Orexin receptor type 1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
- Available For Licensing Yes - Drug abuse
Highest Development Phases
- Preclinical Drug abuse